Drug Profile
Antivenom PolongaTAb - Protherics
Alternative Names: PolongaTAb; Russell's viper antivenom PolongaTAb - ProthericsLatest Information Update: 23 Nov 2009
Price :
$50
*
At a glance
- Originator Protherics
- Developer Symbion Health
- Class Antibodies; Antivenins
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Snake venom poisoning
Most Recent Events
- 12 Jan 2006 Mayne Group is now called Symbion Health
- 18 Oct 1999 Therapeutic Antibodies has merged with Proteus International to form Protherics
- 27 Jul 1999 Preregistration for Snake venom poisoning in South-East Asia (Unknown route)